Biocode Technologies researches, incubates and commercialises inflammation-centred medical technologies. They concentrate specifically on diagnostic solutions that contribute to the management and improvement of human health and wellbeing. Their expanding brand family currently comprises Biocheck, which focuses on rapid testing, and Biolab, which focuses on diagnostic methodologies.

Biocode Technologies researches, incubates and commercialises inflammation-centred medical technologies. They concentrate specifically on diagnostic solutions that contribute to the management and improvement of human health and wellbeing. Their expanding brand family currently comprises Biocheck, which focuses on rapid testing, and Biolab, which focuses on diagnostic methodologies.

Sawubona Mycelium is a South African biotechnology company harnessing the power of African medicinal fungi to create sustainable, high-value bio-based ingredients for industries such as personal care, functional foods, pharmaceuticals, and beverages. Founded in 2018 and based in Centurion, the company integrates fermentation science, indigenous knowledge, and AI-driven data analytics to unlock novel biomolecules from a library of over 3,000 fungal strains sourced across Southern Africa.